Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-28 4:30 pm Unchanged |
2025-03-27 | 13D | Spero Therapeutics, Inc. SPRO |
GLAXOSMITHKLINE PLC | 9,190,606 16.400% |
0 (Unchanged) |
Filing History |
| 2025-03-07 2:22 pm Purchase |
2024-12-31 | 13G | GSK plc GSK |
BLACKROCK INC BLK |
369,576,114 8.900% |
369,576,114 (New Position) |
Filing History |
| 2024-11-15 4:20 pm Purchase |
2024-11-12 | 13D | 23andMe Holding Co. ME |
GLAXOSMITHKLINE PLC | 1,983,025 9.500% |
1,983,025 (New Position) |
Filing History |
| 2024-11-12 4:32 pm Purchase |
2024-09-30 | 13G | Wave Life Sciences Ltd. WVE |
GLAXOSMITHKLINE PLC | 16,775,691 11.200% |
16,775,691 (New Position) |
Filing History |
| 2024-03-28 5:06 pm Unchanged |
2024-03-25 | 13D | Nkarta, Inc. NKTX |
GLAXOSMITHKLINE PLC | 3,161,432 4.500% |
0 (Unchanged) |
Filing History |
| 2024-02-13 1:37 pm Purchase |
2023-12-31 | 13G | GSK plc GSK |
DODGE & COX | 102,084,740 5.800% |
6,254,900 (+6.53%) |
Filing History |
| 2024-02-09 4:18 pm Purchase |
2024-02-07 | 13D | Haleon plc HLN |
GLAXOSMITHKLINE PLC | 39,660,487 11.200% |
39,660,487 (New Position) |
Filing History |
| 2024-02-06 5:10 pm Purchase |
2023-12-31 | 13G | CureVac N.V. CVAC |
GLAXOSMITHKLINE PLC | 16,591,937 7.400% |
1,656,216 (+11.09%) |
Filing History |
| 2024-02-06 5:07 pm Purchase |
2023-12-31 | 13G | Wave Life Sciences Ltd. WVE |
GLAXOSMITHKLINE PLC | 13,983,761 11.500% |
3,300,000 (+30.89%) |
Filing History |
| 2024-01-19 4:20 pm Sale |
2024-01-19 | 13D | Haleon plc HLN |
GLAXOSMITHKLINE PLC | 385,320,110 4.200% |
-352,812,612 (-47.80%) |
Filing History |
| 2023-10-10 4:07 pm Sale |
2023-10-10 | 13D | Haleon plc HLN |
GLAXOSMITHKLINE PLC | 738,132,722 8.000% |
-270,000,000 (-26.78%) |
Filing History |
| 2023-09-11 4:37 pm Unchanged |
2023-09-11 | 13D | Haleon plc HLN |
GLAXOSMITHKLINE PLC | 1,008,132,722 10.900% |
0 (Unchanged) |
Filing History |
| 2023-07-19 6:29 pm Unchanged |
2023-07-17 | 13D | Bicycle Therapeutics plc BCYC |
GLAXOSMITHKLINE PLC | 1,529,561 4.400% |
0 (Unchanged) |
Filing History |
| 2023-05-16 5:27 pm Sale |
2023-05-16 | 13D | Haleon plc HLN |
GLAXOSMITHKLINE PLC | 1,008,132,722 10.900% |
-187,187,388 (-15.66%) |
Filing History |
| 2023-02-14 1:54 pm Purchase |
2022-12-31 | 13G | GSK plc GSK |
DODGE & COX | 95,829,840 5.500% |
95,829,840 (New Position) |
Filing History |
| 2023-02-06 4:06 pm Unchanged |
2022-12-31 | 13G | CVRx, Inc. CVRX |
GLAXOSMITHKLINE PLC | 1,007,583 4.900% |
0 (Unchanged) |
Filing History |
| 2023-01-30 4:37 pm Purchase |
2023-01-23 | 13G | Wave Life Sciences Ltd. WVE |
GLAXOSMITHKLINE PLC | 10,683,761 10.950% |
10,683,761 (New Position) |
Filing History |
| 2023-01-20 4:08 pm Unchanged |
2022-11-07 | 13D | 23andMe Holding Co. ME |
GLAXOSMITHKLINE PLC | 1,983,024 12.200% |
0 (Unchanged) |
Filing History |
| 2023-01-20 4:08 pm Unchanged |
2022-11-14 | 13D | Spero Therapeutics, Inc. SPRO |
GLAXOSMITHKLINE PLC | 9,190,606 17.750% |
0 (Unchanged) |
Filing History |
| 2022-11-14 5:02 pm Purchase |
2022-11-07 | 13D | Spero Therapeutics, Inc. SPRO |
GLAXOSMITHKLINE PLC | 9,190,606 19.990% |
7,450,000 (+428.01%) |
Filing History |